⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARMP News
Armata Pharmaceuticals, Inc. Common Stock
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
prnewswire.com
ARMP
Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
prnewswire.com
ARMP
Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
prnewswire.com
ARMP
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
prnewswire.com
ARMP